The February 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 17, Issue 1
Editorial
Applying design thinking to biotechnology | |
Yali Friedman |
Commentary
Building biotechnology by design: An entrepreneur’s perspective | |
Arthur A Boni |
Building biotechnology by design: Role of biotechnology in development | |
Patrick Nef |
Articles
Pricing biologics: Issues, strategic priorities and a conceptual model | |
Sanjay K Rao |
Revitalizing portfolio decision-making at Merck Serono S.A. – Geneva | |
Vincent Aurentz, Bernhard Kirschbaum, Markus Thunecke |
Global consensus – Need of the hour for genetically modified organisms (GMO) labeling | |
Jagadeesan Premanandh |
Beyond investment: Advancing the biotechnology sector in the countries of the Gulf Cooperation Council (GCC) | |
Leonard Lerer, Brett Bowman |
Case Study
Repurposing of the epidermal growth factor | |
Ernesto L Mola, José A Buxadó, Luis Herrera |
Biotechnology commercialization: A case study from Central and Eastern Europe | |
Dana Ukropcova, Ernest Sturdik |
The developments in the business models of biotechnology in the Central and Eastern European countries: The example of Estonia | |
Margit Suurna |
Legal and Regulatory Updates
EU Legal and Regulatory Update | |
Gerry Kamstra |